« Previous AbstractMetabolome based volatiles mapping of roasted umbelliferous fruits aroma via HS-SPME GC/MS and peroxide levels analyses    Next AbstractChemical factors controlling oviposition of Lutzomyia longipalpis (Diptera: Psychodidae) »

Birth Defects Res B Dev Reprod Toxicol

Title:		Efficacy of Ginkgo biloba on vaginal estrous and ovarian histological alterations for evaluating anti-implantation and abortifacient potentials in albino female mice
Author(s):		Elmazoudy RH; Attia AA;
Address:		"Zoology Department, Alexandria University, Alexandria, Egypt"
Journal Title:		Birth Defects Res B Dev Reprod Toxicol
Year:		2012
Volume:		20121204
Issue:		6
Page Number:		444 - 459
DOI:		10.1002/bdrb.21032
ISSN/ISBN:		1542-9741 (Electronic) 1542-9733 (Linking)
Abstract:		"Ginkgo extract, EGb 761 is known as a vasoregulatory variable for the conventional reproduction therapy. EGb 761 was orally administered in 0 (control), 3.7, 7.4, and 14.8 mg/kg bw/day for 28 days (thereafter mated with normal fertile male), from day 1 to day 7 of pregnancy or from the 10th to 18th day of pregnancy, respectively. Vaginal smears were performed daily. On 20th day of pregnancy, the females were killed by cervical dislocation and their kidneys, liver, brain, placenta, spleen and ovaries were removed and weighed. The ovaries were prepared for histological examinations, and then ovarian follicles were counted. Maternal toxicity, estrous cycle, reproductive hormones, ovarian follicle counts, resorption index, implantation index, fetal viability and fetuses, and placenta mean weights were evaluated. There was a dose-dependent ovarian toxic effect of EGb 761. Ovarian follicle counts, resorption index, implantation index, fetal viability were significantly reduced in 14.8 mg/kg bw/day dose. Treatment with 14.8 mg/kg bw/day EGb 761 induced disruption of estrous cycle and caused maternal toxicity, in addition to fetal toxicity. Therefore, the data obtained indicate that Ginkgo biloba extract at 14.8 mg/kg bw/day dose level exhibit toxic effect on reproductive cyclicity and could have anti-implantation and abotifacient properties in female mice"
Keywords:		"Abortifacient Agents/*pharmacology Administration, Oral Animals Dose-Response Relationship, Drug Embryo Implantation/*drug effects Estrous Cycle/*drug effects Female Fetal Development/drug effects Fetal Resorption/chemically induced Fetal Viability/drug e;"
Notes:		"MedlineElmazoudy, Reda H Attia, Azza A eng 2012/12/06 Birth Defects Res B Dev Reprod Toxicol. 2012 Dec; 95(6):444-59. doi: 10.1002/bdrb.21032. Epub 2012 Dec 4"